Related Experiment Videos
Double-blind, crossover, placebo-controlled clinical trial with clobetasol propionate in desquamative gingivitis
Ana Carolina Fragoso Motta1, Carina Domaneschi, Marilena Chinali Komesu
1Department of Oral Diagnosis, University of São Paulo, SP, Brazil.
Abstract:
The aim of this study was to evaluate the efficacy of a 0.05% clobetasol propionate ointment administered in trays to 22 patients with desquamative gingivitis in a double-blind, crossover, placebo-controlled trial. Patients received container number 1 and were instructed to apply the ointment 3 times a day for 2 weeks, and to reduce the application to once a day in the third week. Next, the patients were then instructed to discontinue the treatment for 2 weeks, and were then given container 2, used in the same way and for the same length of time as container 1. Regarding signs, 17 patients presented some improvement, while 5 experienced worsening with clobetasol propionate. With the placebo, 14 patients presented some improvement, and 8 patients presented worsening. For symptoms, there was complete improvement in 2 patients, partial improvement in 12, no response in 7, and worsening in 1 with clobetasol propionate. With the placebo, there was partial improvement in 8 patients, no response in 12 and worsening in 2. No statistically significant difference was found between clobetasol and placebo (p>0.05). Within the period designed to treat the gingival lesions of the patients, clobetasol propionate did not significantly outperform the placebo.
Related Concept Videos
Blinding
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Blind Procedures
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview